Impact of personalized diabetes care on distress and treatment satisfaction in people with breast cancer
Authors' conclusion
Personalized diabetes care models that emphasize remote management and optimize access for those with BCa may lower DD and improve DTS.
Study context
- Population
- Women in active treatment or surveillance for breast cancer with DM and HbA1c >53 mmol/mol (7%) or random blood glucose >11.1 mmol/L; median age 61 (IQR 49.0–69.0)women enrolled
- Participants
- 31 women
- Exposure
- Personalized diabetes care model: before vs 3 and 6 months
- Outcome
- Diabetes distress (Diabetes Distress Survey, Diabetes Distress Survey (DDS)) and diabetes treatment satisfaction (Diabetes Treatment Satisfaction Questionnaire (DTSQ))
- Follow-up
- 0, 3 and 6 months
Main finding
As reported in the abstract
3 and 6 months
- 3 months vs Baseline: P = 0.004
- 6 months vs Baseline: P = 0.002
- 3 months vs Baseline: P < 0.001
- 6 months vs Baseline: P < 0.001
Observational data: associations, not effects.
Original publication
Impact of personalized diabetes care on distress and treatment satisfaction in people with breast cancer. Diabet Med. Published 30 January 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →